One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   COVID-19 Diagnostics Market

COVID-19診断市場ー業界洞察、主要プレーヤー・企業別、成長機会別、最新傾向別、開発別、主要な成長ドライバー別、主要な課題別によってセグメンテーション、予測 2028年


[ 英語タイトル ] COVID-19 Diagnostics Market by Product & Service (Instruments, Reagents & Kits, and Services), Sample Type (Nasopharyngeal Swabs, Oropharyngeal Swabs, Nasal Swabs, Blood, and Others), Test Type (Molecular, Antigen-based, Antibody-based, and Others), Mode (Point-of-care and Non Point-of-care), End User (Laboratories, Hospitals, Diagnostic Centers & Clinics, and Others), and Regional Analysis (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2021-


Product Code : RDHC00115193
Survey : Research Dive
Publish On : September, 2021
Category : Healthcare and Pharmaceuticals
Report format : PDF
Sales price option (consumption tax not included)
Single User USD5700 / Question Form
5 User USD8700 / Question Form
Enterprise User USD10700 / Question Form
Hologic Inc., Veredus Laboratories, ADT Biotech, Mylab Discovery Solutions Pvt. Ltd., Neuberg Diagnostics, Luminex Corporation, Quidel Corporation, and Quest Diagnostics.

[Report Description]

According to Research Dive analysis, the COVID-19 diagnostic market is estimated to generate a revenue of $65,750.1 million by 2028, increasing from $49,000.90 million in 2020, at a healthy CAGR of 3.5%.
Impact Analysis of COVID-19 on the COVID-19 Diagnostic Market:
The COVID-19 diagnostic market experienced an accelerating growth rate during the Covid-19 pandemic. Due to continuous rise in the corona virus infection cases, the demand and supply for testing kits, equipments, reagents and analyzers have increased due to which the diagnostic market has expanded. Also, initiating mass testing drive by the government of various countries for their people have also increased the market revenue. Apart from this, many COVID-19 testing laboratories have been established to cater the increasing corona virus cases which has also impacted the market growth in the pandemic period.
COVID-19 Diagnostic Market Analysis:
Increasing number of corona virus infection cases, across the world is expected to raise the market for COVID-19 Diagnostics in the forecast timeframe. The coronavirus infection has brought many severe respiratory diseases which has taken many lives so far. Thus, timely diagnoses and proper treatment of the infected people have become the need of the hour. Thus, the demand for the COVID-19 diagnostic is likely to surge in the next few years. Also, government initiatives to conduct mass testing in their areas will impede the growth of the market, further.
However, lack of knowledge about the importance of diagnosis in the rural region of the countries is expected to hinder the market of COVID-19 diagnostics in the future. Apart from this, a gradual decline in the corona virus cases is further expected to decrease the market revenue.
Due to high demand for rapid diagnosis of COVID-19 infection in the patients, the manufacturing companies have got a tremendous opportunity to explore their research and development facility and develop rapid test kits that can provide accurate test results in a very less time frame. Also, bulk purchasing of the diagnostic kits by the healthcare sector have pushed the manufacturing units of the companies to produce more number of kits.
Based on products & services, the COVID-19 diagnostic market is segmented into instruments, reagents & kits and services. The reagents & kits sub-segment shall have the fastest market growth and it is anticipated to generate a revenue of $ 23,435.90 million by 2028.
Based on sample type, the market has been sub-segmented into nasopharyngeal swabs, oropharyngeal swabs, nasal swabs, blood and others. The nasopharyngeal swabs sub-segment is expected to garner $ 26,485.50 million in 2028.
Based on the test type, the market has been divided into molecular, antigen-based, antibody-based, and others. The molecular test sub-segment is predicted to be growing significantly and it is expected to cross $ 38,025.50 million by 2028.
Based on mode, the market has been divided into point-of-care and non point-of-care. The non point-of-care of the market is predicted to have a rapid growth and it is expected to surpass $27,223.90 million by 2028.
Based on end-user, the market has been divided into laboratories, hospitals, diagnostic centers & clinics and others. The diagnostic centers and clinics of the market is predicted to have a rapid growth and it is expected to surpass $ 16,047.30 million by 2028.

Based on geographical scope, the market was investigated across North America, Europe, Asia-Pacific, and LAMEA. The share of Asia-Pacific COVID-19 diagnostic market is anticipated to grow at a CAGR of 4.60% by registering a revenue of $17,949.80 million by 2028.
The companies involved in the COVID-19 diagnostic market are Hologic Inc., Veredus Laboratories, ADT Biotech, Mylab Discovery Solutions Pvt. Ltd., Neuberg Diagnostics, Luminex Corporation, Quidel Corporation, and Quest Diagnostics.

CHAPTER 1:INTRODUCTION

1.1.Research methodology

1.1.1.Desk research
1.1.2.Real-time insights and validation
1.1.3.Forecast model
1.1.4.Assumptions & forecast parameters

1.1.4.1.Assumptions
1.1.4.2.Forecast parameters

CHAPTER 2:EXECUTIVE SUMMARY

2.1.360° summary
2.2.Product & Service trends
2.3.Sample type trends
2.4.Test Type
2.5.Mode
2.6.End User

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key takeaways

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.2.2.1.Top winning strategies, by year
3.2.2.2.Top winning strategies, by development
3.2.2.3.Top winning strategies, by company

3.2.3.Top player positioning

3.3.Porter's five forces analysis
3.4.Market dynamics
3.5.Drivers

3.5.1.Increasing corona virus cases

3.6.Restraints

3.6.1.Lack of awareness regarding diagnostic procedures

3.7.Opportunities

3.7.1.Technological advancements in the diagnostic methods to propel the market growth

3.8.Technology landscape
3.9.Regulatory landscape
3.10.Market value chain analysis
3.11.Strategic overview

CHAPTER 4:IMPACT OF COVID19 ON COVID-19 DIAGNOSTIC MARKET

4.1.Introduction
4.2.COVID-19 health assessment
4.3.Impact of COVID-19 on the global economy
4.4.Impact of COVID-19 on global COVID-19 diagnostic market

4.4.1.Technological impact
4.4.2.Investment scenario

4.5.COVID-19 diagnostic aircraft market size and forecast, by region, 2026-2033

CHAPTER 5:GLOBAL COVID-19 DIAGNOSTIC MARKET, BY PRODUCTS & SERVICES

5.1.Overview

5.1.1.Market size and forecast, by products & services

5.2.Instruments

5.2.1.Key market trends, growth factors and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market share analysis, by country

5.3.Reagents and kits

5.3.1.Key market trends, growth factors and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market share analysis, by country

5.4.Services

5.4.1.Key market trends, growth factors and opportunities
5.4.2.Market size and forecast, by region
5.4.3.Market share analysis, by country

CHAPTER 6:GLOBAL COVID-19 DIAGNOSTIC MARKET, BY SAMPLE TYPE

6.1.Overview

•Nasopharyngeal (NP) Swabs
•Oropharyngeal (OP) Swabs
•Nasal Swabs
•Blood
•Others

6.1.1.Market size and forecast, by sample type

6.2.Nasopharyngeal Swabs

6.2.1.Key market trends, growth factors and opportunities
6.2.2.Market size and forecast, by region
6.2.3.Market share analysis, by country

6.3.Oropharyngeal swab

6.3.1.Key market trends, growth factors and opportunities
6.3.2.Market size and forecast, by region
6.3.3.Market share analysis, by country

6.4.Nasal swab

6.4.1.Key market trends, growth factors and opportunities
6.4.2.Market size and forecast, by region
6.4.3.Market share analysis, by country

6.5.Blood

6.5.1.Key market trends, growth factors and opportunities
6.5.2.Market size and forecast, by region
6.5.3.Market share analysis, by country

6.6.Others

6.6.1.Key market trends, growth factors and opportunities
6.6.2.Market size and forecast, by region
6.6.3.Market share analysis, by country

CHAPTER 7:GLOBAL COVID-19 DIAGNOSTIC MARKET BY TEST TYPE

7.1.Overview

7.1.1.Market size and forecast, by range

7.2.Molecular (PCR) Testing

7.2.1.Key market trends, growth factors and opportunities
7.2.2.Market size and forecast, by region
7.2.3.Market share analysis, by country

7.3.Antigen-based testing

7.3.1.Key market trends, growth factors and opportunities
7.3.2.Market size and forecast, by region
7.3.3.Market share analysis, by country

7.4.Antibody-based testing

7.4.1.Key market trends, growth factors and opportunities
7.4.2.Market size and forecast, by region
7.4.3.Market share analysis, by country

7.5.Others

7.5.1.Key market trends, growth factors and opportunities
7.5.2.Market size and forecast, by region
7.5.3.Market share analysis, by country

CHAPTER 8:GLOBAL COVID-19 DIAGNOSTIC MARKET, BY MODE

8.1.Overview

8.1.1.Market size and forecast, by mode

8.2.Poin-of-Care

8.2.1.Key market trends, growth factors and opportunities
8.2.2.Market size and forecast, by region
8.2.3.Market share analysis, by country

8.3.Non point-of-care

8.3.1.Key market trends, growth factors and opportunities
8.3.2.Market size and forecast, by region
8.3.3.Market share analysis, by country

CHAPTER 9:COVID-19 DIAGNOSTIC MARKET, BY END USER

9.1.Overview

9.1.1.Market size and forecast, by end user

9.2.Laboratories

9.2.1.Key market trends, growth factors and opportunities
9.2.2.Market size and forecast, by region
9.2.3.Market share analysis, by country

9.3.Hospitals

9.3.1.Key market trends, growth factors and opportunities
9.3.2.Market size and forecast, by region
9.3.3.Market share analysis, by country

9.4.Diagnostic centers & clinics

9.4.1.Key market trends, growth factors and opportunities
9.4.2.Market size and forecast, by region
9.4.3.Market share analysis, by country

9.5.Others

9.5.1.Key market trends, growth factors and opportunities
9.5.2.Market size and forecast, by region
9.5.3.Market share analysis, by country

CHAPTER 10:COVID-19 DIAGNOSTIC MARKET, BY REGION

10.1.Overview

10.1.1.Market size and forecast, by region

10.2.North America

10.2.1.Key market trends, growth factors, and opportunities
10.2.2.Market size and forecast, by product & service
10.2.3.Market size and forecast, by sample type
10.2.4.Market size and forecast, by test type
10.2.5.Market size and forecast, by mode
10.2.6.Market size and forecast, by end-user
10.2.7.Market size and forecast, by country
10.2.8.U.S.

10.2.8.1.Market size and forecast, by product & service
10.2.8.2.Market size and forecast, by sample type
10.2.8.3.Market size and forecast, by test type
10.2.8.4.Market size and forecast, by mode
10.2.8.5.Market size and forecast, by end user

10.2.9.Canada

10.2.9.1.Market size and forecast, by product & service
10.2.9.2.Market size and forecast, by sample type
10.2.9.3.Market size and forecast, by test type
10.2.9.4.Market size and forecast, by mode
10.2.9.5.Market size and forecast, by end user

10.2.10.Mexico

10.2.10.1.Market size and forecast, by product & service
10.2.10.2.Market size and forecast, by sample type
10.2.10.3.Market size and forecast, by test type
10.2.10.4.Market size and forecast, by mode
10.2.10.5.Market size and forecast, by end user

10.3.Europe

10.3.1.Key market trends, growth factors, and opportunities
10.3.2.Market size and forecast, by product & service
10.3.3.Market size and forecast, by sample type
10.3.4.Market size and forecast, by test type
10.3.5.Market size and forecast, by mode
10.3.6.Market size and forecast, by end user
10.3.7.Market size and forecast, by country

10.3.8.Germany

10.3.8.1.Market size and forecast, by product & service
10.3.8.2.Market size and forecast, by sample type
10.3.8.3.Market size and forecast, by test type
10.3.8.4.Market size and forecast, by mode
10.3.8.5.Market size and forecast, by end user

10.3.9.UK

10.3.9.1.Market size and forecast, by product & service
10.3.9.2.Market size and forecast, by sample type
10.3.9.3.Market size and forecast, by test type
10.3.9.4.Market size and forecast, by mode
10.3.9.5.Market size and forecast, by end user

10.3.10.France

10.3.10.1.Market size and forecast, by product & service
10.3.10.2.Market size and forecast, by sample type
10.3.10.3.Market size and forecast, by test type
10.3.10.4.Market size and forecast, by mode
10.3.10.5.Market size and forecast, by end user

10.3.11.Italy

10.3.11.1.Market size and forecast, by product & service
10.3.11.2.Market size and forecast, by sample type
10.3.11.3.Market size and forecast, by test type
10.3.11.4.Market size and forecast, by mode
10.3.11.5.Market size and forecast, by end user

10.3.12.Spain

10.3.12.1.Market size and forecast, by product & service
10.3.12.2.Market size and forecast, by sample type
10.3.12.3.Market size and forecast, by test type
10.3.12.4.Market size and forecast, by mode
10.3.12.5.Market size and forecast, by end user

10.3.13.Rest of Europe

10.3.13.1.Market size and forecast, by product & service
10.3.13.2.Market size and forecast, by sample type
10.3.13.3.Market size and forecast, by test type
10.3.13.4.Market size and forecast, by mode
10.3.13.5.Market size and forecast, by end user

10.4.Asia-Pacific

10.4.1.Key market trends, growth factors, and opportunities
10.4.2.Market size and forecast, by product & service
10.4.3.Market size and forecast, by sample type
10.4.4.Market size and forecast, by test type
10.4.5.Market size and forecast, by mode
10.4.6.Market size and forecast, by maximum end user
10.4.7.Market size and forecast, by country
10.4.8.China

10.4.8.1.Market size and forecast, by product & service
10.4.8.2.Market size and forecast, by sample type
10.4.8.3.Market size and forecast, by test type
10.4.8.4.Market size and forecast, by mode
10.4.8.5.Market size and forecast, by end user

10.4.9.Japan

10.4.9.1.Market size and forecast, by product & service
10.4.9.2.Market size and forecast, by sample type
10.4.9.3.Market size and forecast, by test type
10.4.9.4.Market size and forecast, by mode
10.4.9.5.Market size and forecast, by end user

10.4.10.Australia

10.4.10.1.Market size and forecast, by product & service
10.4.10.2.Market size and forecast, by sample type
10.4.10.3.Market size and forecast, by test type
10.4.10.4.Market size and forecast, by mode
10.4.10.5.Market size and forecast, by end user

10.4.11.South Korea

10.4.11.1.Market size and forecast, by product & service
10.4.11.2.Market size and forecast, by sample type
10.4.11.3.Market size and forecast, by test type
10.4.11.4.Market size and forecast, by mode
10.4.11.5.Market size and forecast, by end user

10.4.12.India

10.4.12.1.Market size and forecast, by product & service
10.4.12.2.Market size and forecast, by sample type
10.4.12.3.Market size and forecast, by test type
10.4.12.4.Market size and forecast, by mode
10.4.12.5.Market size and forecast, by end user

10.4.13.Rest of Asia-Pacific

10.4.13.1.Market size and forecast, by product & services
10.4.13.2.Market size and forecast, by sample type
10.4.13.3.Market size and forecast, by test type
10.4.13.4.Market size and forecast, by mode
10.4.13.5.Market size and forecast, by end user

10.5.LAMEA

10.5.1.Key market trends, growth factors, and opportunities
10.5.2.Market size and forecast, by product & service
10.5.3.Market size and forecast, by sample type
10.5.4.Market size and forecast, by test type
10.5.5.Market size and forecast, by mode
10.5.6.Market size and forecast, by end user
10.5.7.Market size and forecast, by country

10.5.8.Latin America

10.5.8.1.Market size and forecast, by product & service
10.5.8.2.Market size and forecast, by sample type
10.5.8.3.Market size and forecast, by test type
10.5.8.4.Market size and forecast, by mode
10.5.8.5.Market size and forecast, by end user

10.5.9.Middle East

10.5.9.1.Market size and forecast, by product & service
10.5.9.2.Market size and forecast, by sample type
10.5.9.3.Market size and forecast, by test type
10.5.9.4.Market size and forecast, by mode
10.5.9.5.Market size and forecast, by end user

10.5.10.Africa

10.5.10.1.Market size and forecast, by product & service
10.5.10.2.Market size and forecast, by sample type
10.5.10.3.Market size and forecast, by test type
10.5.10.4.Market size and forecast, by mode
10.5.10.5.Market size and forecast, by end user

CHAPTER 11:COMPANY PROFILES

11.1.Quidel Corporation

11.1.1.Company overview
11.1.2.Company snapshot
11.1.3.Operating business segments
11.1.4.Product portfolio
11.1.5.Business performance
11.1.6.Key strategic moves and developments

11.2.HOLOGIC INC.

11.2.1.Company overview
11.2.2.Company snapshot
11.2.3.Business performance
11.2.4.Key strategic moves and developments

11.3.Veredus Laboratories

11.3.1.Company overview
11.3.2.Company snapshot
11.3.3.Product portfolio
11.3.4.Key strategic moves and developments

11.4.Quest Diagnostics

11.4.1.Company overview
11.4.2.Company snapshot
11.4.3.Operating business segments
11.4.4.Product portfolio
11.4.5.Business performance
11.4.6.Key strategic moves and developments

11.5.ADT BIOTECH

11.5.1.Company overview
11.5.2.Company snapshot
11.5.3.Product portfolio
11.5.4.Key strategic moves and developments

11.6.Mylab Discovery Solutions Pvt. Ltd.

11.6.1.Company overview
11.6.2.Company snapshot
11.6.3.Product portfolio
11.6.4.Key strategic moves and developments

11.7.Luminex Corporation

11.7.1.Company overview
11.7.2.Company snapshot
11.7.3.Product portfolio
11.7.4.Business performance
11.7.5.Key strategic moves and development

11.8.NEUBERG DIAGNOSTICS

11.8.1.Company overview
11.8.2.Product portfolio
11.8.3.Key strategic moves and developments

11.9.Laboratory Corporation of America Holdings

11.9.1.Company overview
11.9.2.Company snapshot
11.9.3.Operating business Segments
11.9.4.Product portfolio
11.9.5.Business performance
11.9.6.Key strategic moves and developments

11.10.Abbott Laboratories

11.10.1.Company overview
11.10.2.Company snapshot
11.10.3.Operating business segments
11.10.4.Product portfolio
11.10.5.Business performance
11.10.6.Key strategic moves and developments

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+